Dronabinol (Par Pharmaceutical Inc.)


Welcome to the PulseAid listing for the Dronabinol drug offered from Par Pharmaceutical Inc.. This Cannabinoid [EPC],Cannabinoids [Chemical/Ingredient] pharmaceutical is classified as a HUMAN PRESCRIPTION DRUG. Below, you can view details for this drug, such as its dosage form, route of delivery, start market/end market dates, and more. We have also randomly listed additional pharmaceuticals used in the same HUMAN PRESCRIPTION DRUG drug type category.
LABELER NAME / MANUFACTURER: Par Pharmaceutical Inc.
NON-PROPRIETARY NAME: Dronabinol
SUBSTANCE NAME: DRONABINOL
TYPE: HUMAN PRESCRIPTION DRUG
PHARMA CLASS: Cannabinoid [EPC],Cannabinoids [Chemical/Ingredient]
ROUTE: ORAL
DOSAGE FORM: CAPSULE
MARKETING CATEGORY NAME: ANDA
START MARKETING DATE: 2008-06-27
END MARKETING DATE: 0000-00-00


Dronabinol HUMAN PRESCRIPTION DRUG Details:

Item DescriptionDronabinol from Par Pharmaceutical Inc.
LABELER NAME: Par Pharmaceutical Inc.
DEA SCHEDULE: CIII
ACTIVE STRENGTH: 2.5(mg/1)
START MARKETING DATE: 2008-06-27
END MARKETING DATE: 0000-00-00
PRODUCT ID: 49884-867_f94ee242-3e2f-479f-851f-305d93b82737
PRODUCT NDC: 49884-867
APPLICATION NUMBER: ANDA078292

Other DRONABINOL Pharmaceutical Manufacturers / Labelers:

Manufacturer / LabelerProprietary Name
AbbVie Inc.Marinol
Actavis Pharma, Inc.Dronabinol
Akorn, Inc.Dronabinol
American Health PackagingDronabinol
Insys Therapeutics, Inc.SYNDROS
Mylan Pharmaceuticals Inc.Dronabinol
Par Pharmaceutical Inc.Dronabinol
Physicians Total Care, Inc.Dronabinol